Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 8.65%
March 31, 2026 -40.23%
December 31, 2025 -127.4%
September 30, 2025 1.22%
June 30, 2025 -0.05%
March 31, 2025 0.01%
December 31, 2024 -3.64%
September 30, 2024 -1.62%
June 30, 2024 -9.92%
March 31, 2024 0.38%
December 31, 2023 -2.39%
September 30, 2023 1.37%
June 30, 2023 0.75%
March 31, 2023 -0.09%
December 31, 2022 -1.10%
September 30, 2022 -4.74%
June 30, 2022 -5.79%
March 31, 2022 -0.12%
December 31, 2021 2.90%
September 30, 2021 -5.17%
June 30, 2021 -11.39%
March 31, 2021 0.28%
December 31, 2020 -4.96%
September 30, 2020 -12.74%
June 30, 2020 1.31%
Date Value
March 31, 2020 5.32%
December 31, 2019 -1.44%
September 30, 2019 7.74%
June 30, 2019 0.78%
March 31, 2019 5.44%
December 31, 2018 6.83%
September 30, 2018 -5.95%
June 30, 2018 3.05%
March 31, 2018 6.64%
December 31, 2017 5.71%
September 30, 2017 3.61%
June 30, 2017 -5.63%
March 31, 2017 6.00%
December 31, 2016 -102.1%
September 30, 2016 -126.0%
June 30, 2016 -39.86%
March 31, 2016 -39.29%
December 31, 2015 -7.51%
September 30, 2015 20.50%
June 30, 2015 -1.57%
March 31, 2015 -2.29%
June 30, 2014 11.48%
March 31, 2014 4.79%
December 31, 2013 -8.79%
September 30, 2013 11.94%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 8.65%
Corcept Therapeutics, Inc. 16.45%
Veru, Inc. --
Johnson & Johnson 21.86%
Eli Lilly & Co. 30.88%